Nalaganje...
STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
| Serija: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Teme: | |
| Online dostop: | https://www.rpcardio.com/jour/article/view/192 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|